Breaking News
May 3, 2019 - Vaping and Smoking May Signal Greater Motivation to Quit
May 3, 2019 - Dementia looks different in brains of Hispanics
May 3, 2019 - Short-Staffed Nursing Homes See Drop In Medicare Ratings
May 3, 2019 - Study of teens with eating disorders explores how substance users differ from non-substance users
May 3, 2019 - Scientists develop new video game that may help in the study of Alzheimer’s
May 3, 2019 - Arc Bio introduces Galileo Pathogen Solution product line at ASM Clinical Virology Symposium
May 3, 2019 - Cornell University study uncovers relationship between starch digestion gene and gut bacteria
May 3, 2019 - How to Safely Use Glucose Meters and Test Strips for Diabetes
May 3, 2019 - Anti-inflammatory drugs ineffective for prevention of Alzheimer’s disease
May 3, 2019 - Study tracks Pennsylvania’s oil and gas waste-disposal practices
May 3, 2019 - Creating a better radiation diagnostic test for astronauts
May 3, 2019 - Vegans are often deficient in these four nutrients
May 3, 2019 - PPDC announces seed grants to develop medical devices for children
May 3, 2019 - Study maps out the frequency and impact of water polo head injuries
May 3, 2019 - Research on Reddit identifies risks associated with unproven treatments for opioid addiction
May 3, 2019 - Good smells may help ease tobacco cravings
May 3, 2019 - Medical financial hardship found to be very common among people in the United States
May 3, 2019 - Researchers develop multimodal system for personalized post-stroke rehabilitation
May 3, 2019 - Study shows significant mortality benefit with CABG over percutaneous coronary intervention
May 3, 2019 - Will gene-editing of human embryos ever be justifiable?
May 3, 2019 - FDA Approves Dengvaxia (dengue vaccine) for the Prevention of Dengue Disease in Endemic Regions
May 3, 2019 - Why Tonsillitis Keeps Coming Back
May 3, 2019 - Fighting the opioid epidemic with data
May 3, 2019 - Maggot sausages may soon be a reality
May 3, 2019 - Deletion of ATDC gene prevents development of pancreatic cancer in mice
May 2, 2019 - Targeted Therapy Promising for Rare Hematologic Cancer
May 2, 2019 - Alzheimer’s disease is a ‘double-prion disorder,’ study shows
May 2, 2019 - Reservoir bugs: How one bacterial menace makes its home in the human stomach
May 2, 2019 - Clinical, Admin Staff From Cardiology Get Sneak Peek at Epic
May 2, 2019 - Depression increases hospital use and mortality in children
May 2, 2019 - Vicon and NOC support CURE International to create first gait lab in Ethiopia
May 2, 2019 - Researchers use 3D printer to make paper organs
May 2, 2019 - Viral infection in utero associated with behavioral abnormalities in offspring
May 2, 2019 - U.S. Teen Opioid Deaths Soaring
May 2, 2019 - Opioid distribution data should be public
May 2, 2019 - In the Spotlight: “I’m learning every single day”
May 2, 2019 - 2019 Schaefer Scholars Announced
May 2, 2019 - Podcast: KHN’s ‘What The Health?’ Bye-Bye, ACA, And Hello ‘Medicare-For-All’?
May 2, 2019 - Study describes new viral molecular evasion mechanism used by cytomegalovirus
May 2, 2019 - SLU study suggests a more equitable way for Medicare reimbursement
May 2, 2019 - Scientists discover first gene involved in lower urinary tract obstruction
May 2, 2019 - Researchers identify 34 genes associated with increased risk of ovarian cancer
May 2, 2019 - Many low-income infants receive formula in the first few days of life, finds study
May 2, 2019 - Global study finds high success rate for hip and knee replacements
May 2, 2019 - Taking depression seriously: What is it?
May 2, 2019 - With Head Injuries Mounting, Will Cities Put Their Feet Down On E-Scooters?
May 2, 2019 - Scientists develop small fluorophores for tracking metabolites in living cells
May 2, 2019 - Study casts new light into how mothers’ and babies’ genes influence birth weight
May 2, 2019 - Researchers uncover new brain mechanisms regulating body weight
May 2, 2019 - Organ-on-chip systems offered to Asia-Pacific regions by Sydney’s AXT
May 2, 2019 - Adoption of new rules drops readmission penalties against safety net hospitals
May 2, 2019 - Kids and teens who consume zero-calorie sweetened beverages do not save calories
May 2, 2019 - Improved procedure for cancer-related erectile dysfunction
May 2, 2019 - Hormone may improve social behavior in autism
May 2, 2019 - Alzheimer’s disease may be caused by infectious proteins called prions
May 2, 2019 - Even Doctors Can’t Navigate Our ‘Broken Health Care System’
May 2, 2019 - Study looks at the impact on criminal persistence of head injuries
May 2, 2019 - Honey ‘as high in sugars as table sugar’
May 2, 2019 - Innovations to U.S. food system could help consumers in choosing healthy foods
May 2, 2019 - FDA Approves Mavyret (glecaprevir and pibrentasvir) as First Treatment for All Genotypes of Hepatitis C in Pediatric Patients
May 2, 2019 - Women underreport prevalence and intensity of their own snoring
May 2, 2019 - Concussion summit focuses on science behind brain injury
May 2, 2019 - Booker’s Argument For Environmental Justice Stays Within The Lines
May 2, 2019 - Cornell research explains increased metastatic cancer risk in diabetics
May 2, 2019 - Mount Sinai study provides fresh insights into cellular pathways that cause cancer
May 2, 2019 - Researchers to study link between prenatal pesticide exposures and childhood ADHD
May 2, 2019 - CoGEN Congress 2019: Speakers’ overviews
May 2, 2019 - A new strategy for managing diabetic macular edema in people with good vision
May 2, 2019 - Sagent Pharmaceuticals Issues Voluntary Nationwide Recall of Ketorolac Tromethamine Injection, USP, 60mg/2mL (30mg per mL) Due to Lack of Sterility Assurance
May 2, 2019 - Screen time associated with behavioral problems in preschoolers
May 2, 2019 - Hormone reduces social impairment in kids with autism | News Center
May 2, 2019 - Researchers synthesize peroxidase-mimicking nanozyme with low cost and superior catalytic activity
May 2, 2019 - Study results of a potential drug to treat Type 2 diabetes in children announced
May 2, 2019 - Multigene test helps doctors to make effective treatment decisions for breast cancer patients
May 2, 2019 - UNC School of Medicine initiative providing unique care to dementia patients
May 2, 2019 - Nestlé Health Science and VHP join forces to launch innovative COPES program for cancer patients
May 2, 2019 - Study examines how our brain generates consciousness and loses it during anesthesia
May 2, 2019 - Transition Support Program May Aid Young Adults With Type 1 Diabetes
May 2, 2019 - Study shows how neutrophils exacerbate atherosclerosis by inducing smooth muscle-cell death
May 2, 2019 - Research reveals complexity of how we make decisions
TMJ disorders could be treated with tissue-engineered implants after successful animal study

TMJ disorders could be treated with tissue-engineered implants after successful animal study

It’s estimated that around 10 million Americans experience a temporomandibular joint (TMJ) disorder, with women being more susceptible than men. Affecting the jaw joint, TMJ disorders are characterized by pain around the jaw, ear, and temple, as well as difficulties in opening the mouth and significant clicking or grinding noises brought on by jaw movement.

Shutterstock | Sebastian Kaulitzki

Despite the high incidence rates of the disorders, there are not many treatments and cures that go beyond palliative measures.

Kyriacos A. Athanasiou, Distinguished Professor of biomedical engineering at the University of California, Irvine, is the senior author on a paper recently published in the Cell Press journal Trends in Molecular Medicine. The paper investigates why temporomandibular disorders occur, interrogates failures in treating the disorders in the past, and looks at novel approaches to treating the disorders. These new approaches include using tissue-engineering innovations from his own laboratory.

Senior co-authors are Ryan Donahue, a UCI graduate student researcher in biomedical engineering, and Jerry Hu, UCI principle development engineer in biomedical engineering.

Athanasiou explained the effects of TMJ disorders on daily life.

“The TMJ is central to chewing, talking and so many other daily activities, so when this crucial joint is impaired, there are significant negative effects on quality of life.

“The problem may start with slight pain and clicking and get progressively worse to the point where it’s not just impacting the jaw but the entire body.”

TMJ disorders can occur after an injury, natural wear to the joint over time, or an uneven bite. Anxiety disorders and stress can also result in a temporomandibular joint disorder through increased, subconscious clenching of the jaw both during the day and while a person is asleep. Typically, problems with the jaw joint in these disorders are due to thinning or perforation of the disc between the mandible and temporal bone.

Athanasiou describes a “TMJ gender paradox” in a book published in 2009 called Tissue Engineering of Temporomandibular Joint Cartilage, with reports stating that female-to-male patient prevalence varies from 3:1 to 8:1. It also says that pain onset in TMJ patients is most prevalent in women between the ages of 20 to 40 years old.

On the merit of tissue engineering as a new approach for treatment, Athanasiou states in the book that the “lack of an intrinsic regenerative ability in cartilaginous tissues renders them ideal candidates for tissue engineering approaches.”

Treatments for TMJ disorders are lacking despite the joint being similar to many others in the body, like the knees, elbows, hips, and shoulders, for example, for which there are many treatments for cartilaginous disorders.

Athanasiou explains why there are so few operations carried out on the jaw.

“It has to do with the proximity of the TMJ to the brain,” he said. “Back in the 1980s, many patients – primarily women – came forward with issues they had with the TMJ. The solution at the time was to insert a spacer between the two bones articulated in the jaw.”

This particular spacer was made of Teflon, a synthetic resin that has been approved by the US Food and Drug Administration (FDA).

“It turns out that Teflon was an absolute disaster for all of those women,” Athanasiou continued. “Because of the large mechanical forces generated by the jaw, the Teflon broke up into pieces, and because of the proximity of the TMJ to the brain, those pieces somehow found their way into the brain.”

In Tissue Engineering of Temporomandibular Joint Cartilage, Athanasiou describes how the catastrophic failures of the 1980s Teflon treatment for TMJ have “tainted all forms of TMJ surgery and discouraged many surgeons from seeking alternative methods to reconstruct the joint.” He also points out that “despite the immense suffering” the patients affected by failures in the Teflon treatment, the “lessons learned from this experience are essential.”

The new treatments Athanasiou and his team do not use synthetic materials at all, instead involve developing biological TMJ discs that will be suitable for use in humans.

“The end product that we aspire to use for treating afflictions of TMJ discs is a tissue-engineered product that’s fully alive, biological and mechanically comparable to the real thing,” Donahue said. “So even if it breaks down, it will be like any other biological component, without having pieces of foreign material entering the brain.”

Results from work carried out by Athanasiou’s research team were published in Science Translation Medicine in 2018. Their work saw them successfully grow cells from the rib cartilage of a Yucatan miniature pig and implant the tissue-engineered construct into another animal.

Contrary to many methods used by researchers, which would see the bioengineered cells placed in another part of the animal’s body, Athanasiou emphasized the importance of placing the new disc in exactly the same place from where they were taken from the first animal. This is so the new disc will experience the same natural stresses of the joint.

Hu elaborated on the success of the implantation:

“In eight weeks, we saw complete functionality of the TMJ disc, whereas the ones we left untreated deteriorated completely, developing full osteoarthritis in the joint.

“So we were able to show that by using our tissue-engineering approach in a large-animal model, we could achieve exceptional healing.”

Goals for the future include carrying out further trials in other large animals to ascertain if this particular treatment would be suitable for humans. Although there were concerns about having their treatment approved by the FDA, Athanasiou says:

“The FDA has asked if we could help them figure out how to go about developing processes for bringing TMJ products to the market.”

He goes on to say that they would be “delighted to help create that pathway.”

Tagged with:

About author

Related Articles